Gilead Viread approval
Executive Summary
FDA approves tenofovir Oct. 26 for treatment of HIV-1 infection when used in combination with other antiretroviral agents. Gilead expects Viread will be in pharmacies "within days." FDA's Antiviral Drugs Advisory Committee suggested Oct. 3 that use of Viread be limited to use in treatment-experienced patients (1"The Pink Sheet" Oct. 8, p. 30)